WHAT WE DO
We are a contract manufacturing organization (CMO) that specializes in the GMP manufacture and sterile fill/finish of vials for clinical trials and low volume commercial supply.
Our biological and small molecule production capabilities support biotech and pharmaceutical companies in North America that require the contract manufacturing of injectables for supply into Europe and across the US.
Our European fill finish facility was purpose-built to meet increasing market demand from emerging biotech companies that require small-scale, shorter sterile drug product development timelines, while consistently maintaining regulatory compliance.
We reliably support our customers with the aseptic filling and lyophilization of conventional, biologic and cytotoxic drugs into vials. Helping clients across North America meet their project milestones and clinical deadlines, we provide rapid access to manufacturing slots and quick release of drug product to ensure tight timelines are successfully met.
We built our European contract manufacturing facility in Stirling, Scotland in 2011 with technical capability, quality assurance and operational flexibility at its core. Its design gives you quick access to production slots to progress to batch release in less time, without any compromise on quality.
Manufacturing takes place within a purpose-built MHRA-licensed facility, enabling us to fill bulk volumes <100 liters. This includes products such as monoclonal antibodies (mAbs), proteins, peptides, Ribonucleic Acid (RNA), cytotoxic, cytostatic and high potent APIs including antibody drug conjugates (ADCs).
Once again, Symbiosis Pharmaceutical Services will be exhibiting at BIO International Convention.The biggest event in the… Read More
Colin MacKay, CEO of Symbiosis Pharmaceutical Services, recently took part in a Q&A interview with BioProcess… Read More